InflaRx (IFRX) Equity Ratio (2022 - 2025)

InflaRx (IFRX) has disclosed Equity Ratio for 4 consecutive years, with 0.75 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 6.84% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, down 6.84% year-over-year, with the annual reading at 0.75 for FY2025, 6.84% down from the prior year.
  • Equity Ratio hit 0.75 in Q4 2025 for InflaRx, down from 0.81 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.86 in Q4 2022 to a low of 0.75 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.82 across 4 years, with a median of 0.83 in 2023.
  • Biggest five-year swings in Equity Ratio: fell 1.09% in 2023 and later dropped 6.84% in 2025.
  • Year by year, Equity Ratio stood at 0.86 in 2022, then decreased by 1.09% to 0.85 in 2023, then decreased by 5.33% to 0.81 in 2024, then decreased by 6.84% to 0.75 in 2025.
  • Business Quant data shows Equity Ratio for IFRX at 0.75 in Q4 2025, 0.81 in Q4 2024, and 0.85 in Q4 2023.